日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC

肿瘤细胞FAP在侵袭性局限性透明细胞肾细胞癌中调控EMT和免疫抑制。

Pellinen, Teijo; Luomala, Lassi; Mattila, Kalle E; Hemmes, Annabrita; Välimäki, Katja; Arjama, Mariliina; Brück, Oscar; Paavolainen, Lassi; Kankkunen, Elisa; Nisén, Harry; Järvinen, Petrus; Castillon, Leticia; Vanharanta, Sakari; Vainio, Paula; Kallioniemi, Olli; Jaakkola, Panu M; Mirtti, Tuomas

A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer

利用计算病理学模型预测多西他赛对局限性高危和转移性前列腺癌的疗效

Medina, Sebastian; Tokuyama, Naoto; Hammouda, Kamal; Pathak, Tilak; Mirtti, Tuomas; Fu, Pingfu; Gupta, Shilpa; Lal, Priti; Sandler, Howard M; Correa, Rohann; Chafe, Susan; Shah, Amit; Efstathiou, Jason A; Hoffman, Karen; Straza, Michael; Hallman, Mark A; Jordan, Richard; Pugh, Stephanie L; Sweeney, Christopher J; Madabhushi, Anant

Estrogen metabolism pathways in pregnancy and subsequent breast cancer risk: a prospective follow-up study

妊娠期雌激素代谢途径与后续乳腺癌风险:一项前瞻性随访研究

Troisi, R; Falk, R T; Surcel, H M; Kauppila, S; Mirtti, T; Gissler, M; Sampson, J; Xu, X; Fan, S; Gierach, G L

Oncological Results After Accidental Tumor Incision During Partial Nephrectomy

肾部分切除术中意外切开肿瘤后的肿瘤学结果

Varpela, Markus; Tornberg, Sara; Nisen, Harry; Mirtti, Tuomas; Järvinen, Petrus

Comparable recurrence risk for MRI-detected Gleason Grade Group (GG) 2 and systematic biopsy-detected GG1 prostate cancer

MRI 检测到的 Gleason 分级组 (GG) 2 和系统性活检检测到的 GG1 前列腺癌的复发风险相当

Batouche, Abderrahim-Oussama; Czeizler, Eugen; Lehto, Timo-Pekka; Erickson, Andrew; Shadbahr, Tolou; Laajala, Teemu D; Pohjonen, Joona; Mirtti, Tuomas; Rannikko, Antti S

Validation of fibroblast activation protein and α-smooth muscle actin as prognostic biomarkers in prostate cancer through AI-assisted image analysis of dual-marker IHC

通过人工智能辅助的双标记免疫组化图像分析,验证成纤维细胞活化蛋白和α-平滑肌肌动蛋白作为前列腺癌预后生物标志物的有效性

Säilä, Jenni; Lehto, Timo-Pekka; Rannikko, Antti; Kallioniemi, Olli; Mirtti, Tuomas; Pellinen, Teijo

AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma

人工智能辅助的计算病理分类器可预测肌层浸润性尿路上皮癌不同治疗方式的疗效

Hammouda, Kamal; Tokuyama, Naoto; Corredor, Germán; Pathak, Tilak; Dakarapu, Rishi; Genega, Elizabeth; Mian, Omar Y; Pavicic, Paul G Jr; Diaz-Montero, C Marcela; Mirtti, Tuomas; Farré, Xavier; Gupta, Shilpa; Madabhushi, Anant

Integrin Trafficking, Fibronectin Architecture, and Glomerular Injury upon Adiponectin Receptor 1 Depletion.

脂联素受体 1 耗竭后整合素运输、纤连蛋白结构和肾小球损伤

Lindfors Sonja, Schmotz Constanze, Lewandowski Dominik, Hau Annika, Saikko Leena, Lehtonen Eero, Majaniemi Ville, Karhe Minna, Naams Jette-Britt, Nisen Harry, Tienari Jukka, Saleem Moin A, Pfeil Katharina, Bugger Heiko, Pietiläinen Kirsi H, Mirtti Tuomas, Palczewski Krzysztof, Lehtonen Sanna

Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilities

对离体前列腺癌CAF模型进行分子谱分析,可以揭示基质异质性和药物敏感性。

Rantanen, Frida; Murumägi, Astrid; Arjama, Mariliina; Välimäki, Katja; Multamäki, Elina; Mirtti, Tuomas; Rannikko, Antti; Pellinen, Teijo; Ungureanu, Daniela; Kallioniemi, Olli

Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses.

患者来源的肿瘤外植体模型揭示了肿瘤免疫微环境的独特且可重复的免疫治疗反应

Turpin Rita, Peltonen Karita, Rannikko Jenna H, Liu Ruixian, Kumari Anita N, Nicorici Daniel, Lee Moon Hee, Mutka Minna, Kovanen Panu E, Niinikoski Laura, Meretoja Tuomo, Mattson Johanna, Järvinen Petrus, Lahdensuo Kanerva, Järvinen Riikka, Tornberg Sara, Mirtti Tuomas, Boström Pia, Koskivuo Ilkka, Thotakura Anil, Pouwels Jeroen, Hollmén Maija, Mustjoki Satu, Klefström Juha